Driving in Mild Dementia Decision Tool
Driving in Mild Dementia Decision Tool
| Sponsors |
Lead Sponsor: Sunnybrook Health Sciences Centre Collaborator: Canadian Institutes of Health Research (CIHR) |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| Source | Sunnybrook Health Sciences Centre | ||||||||
| Brief Summary | Based on the literature on dementia and driving, and on knowledge tools available to date including one from our current work, a Driving in Mild Dementia Decision Tool (DMD-DT) will be adapted and tailored to guide physicians in their decisions to report a driver with mild dementia to the provincial licensing agency. The DMD-DT intervention will include a) an algorithm-based computerized clinical decision support system (CCDSS) for facilitating driving assessment and physicians' reporting to provincial transportation authorities, b) an individualized educational package for patients and caregivers about dementia and driving and driving cessation, and c) a modified reporting form to provincial driving regulatory authorities. Months 1 to 6: The DMD-DT will be tailored and adapted to practice with the input of the co-investigators and knowledge-users who represent the perspectives of physicians, patients and their caregivers, as well as transportation authorities. Pilot testing will be done, and input from focus groups of knowledge-users will refine the intervention. Physicians will be recruited to participate in a clinical trial of the DMD-DT. Months 7-18: A parallel-group cluster randomized controlled trial (RCT) will be conducted to compare the effects of the DMD-DT to a legislation reminder on recommendations for reporting to the licensing agency. The effects of the DMD-DT on the doctor-patient relationship will be further explored in focus groups and interviews with physicians. Months 19-24: The knowledge obtained from the study will be used to generalize and sustain use of the intervention beyond Ontario, Canada, and to disseminate the information to knowledge-users. The primary outcome measure is the filing of a report to the Ministry of Transportation of Ontario, indicating that the physician has a concern about the patient's health condition (i.e. mild dementia). The primary outcome of the study is the difference in reporting between the DMD-DT and control arms. Since the current reporting rate is low, approximately 13%, from a public health point of view, the primary outcome expected is that physicians in the DMD-DT group will report more patients with mild dementia than those in the control group. |
||||||||
| Overall Status | Completed | ||||||||
| Start Date | January 2014 | ||||||||
| Completion Date | January 2016 | ||||||||
| Primary Completion Date | January 2016 | ||||||||
| Phase | N/A | ||||||||
| Study Type | Interventional | ||||||||
| Primary Outcome |
|
||||||||
| Secondary Outcome |
|
||||||||
| Enrollment | 68 | ||||||||
| Condition | |||||||||
| Intervention |
Intervention Type: Other Intervention Name: Driving in Mild Dementia Decision Tool Description: Study participants will be screening patients for fitness to drive using our DMD-DT, instead of using their usual care strategies. Arm Group Label: Driving in Mild Dementia Decision Tool |
||||||||
| Eligibility |
Criteria:
Inclusion Criteria: - family physicians and specialist physicians (geriatricians, geriatric psychiatrists, cognitive neurologists) practicing in Ontario, Canada, who assess and treat patients with mild dementia - must speak English and have computer access at the point of delivery of care Exclusion Criteria: - family physicians must see at least 10 new patients per year with mild dementia, and specialist physicians must see at least 12 new patients per year with mild dementia - participants must not have participated in, attended a continuing medical education (CME) event about, or read about our "Dementia and Driving in Ontario" study (2010-2012) Gender: All Minimum Age: N/A Maximum Age: N/A Healthy Volunteers: Accepts Healthy Volunteers |
||||||||
| Overall Official |
|
||||||||
| Location |
|
||||||||
| Location Countries |
Canada |
||||||||
| Verification Date |
February 2016 |
||||||||
| Responsible Party |
Type: Sponsor |
||||||||
| Keywords | |||||||||
| Has Expanded Access | No | ||||||||
| Condition Browse | |||||||||
| Number Of Arms | 2 | ||||||||
| Arm Group |
Label: Driving in Mild Dementia Decision Tool Type: Experimental Description: Participants in this arm will be assessing patients using the Driving in Mild Dementia Decision Tool Label: Control Type: No Intervention Description: Participants will assess patients using their usual care strategies. |
||||||||
| Acronym | DMD-DT | ||||||||
| Patient Data | No | ||||||||
| Study Design Info |
Allocation: Randomized Intervention Model: Parallel Assignment Primary Purpose: Treatment Masking: None (Open Label) |
||||||||